Law360 (April 5, 2011, 3:46 PM EDT) -- Palmetto Pharmaceuticals LLC launched a suit Tuesday in South Carolina alleging AstraZeneca Pharmaceuticals LP’s blockbuster cholesterol-lowering drug Crestor infringes Palmetto’s patent.
The Charleston, S.C.-based drugmaker filed its complaint in the U.S....
Palmetto Targets AstraZeneca’s Crestor In IP Suit
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
